Epidermal growth factor receptor and cyclin D1 are independently amplified and overexpressed in esophageal squamous cell carcinoma
- 19 October 2004
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 131 (2) , 111-119
- https://doi.org/10.1007/s00432-004-0610-7
Abstract
To assess the status of EGFR, HER-2, and CCND1 at the gene and protein levels in esophageal squamous cell carcinoma.Keywords
This publication has 29 references indexed in Scilit:
- Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on PrognosisJournal of Clinical Oncology, 2003
- Epidermal Growth Factor Receptor Dependence in Human Tumors: More Than Just Expression?The Oncologist, 2002
- Anticancer therapy targeting the erbB family of receptor tyrosine kinasesSeminars in Oncology, 2001
- EGFR and cancer prognosisPublished by Elsevier ,2001
- Chromosomal imbalances in gastric and esophageal adenocarcinoma: Specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomasGenes, Chromosomes and Cancer, 2001
- Prognostic significance of CyclinD1 and E-Cadherin in patients with esophageal squamous cell carcinoma: multiinstitutional retrospective analysisJournal of the American College of Surgeons, 2001
- Gene Amplification of int-2 and erbβ in Human Esophageal Cancer: Relationship to Clinicopathological VariablesCancer Investigation, 1997
- Categorical Data Analysis Using the SAS SystemTechnometrics, 1996
- Meanings of c-erbB and int-2 Amplification in Superficial Esophageal Squamous Cell CarcinomasThe Annals of Thoracic Surgery, 1996
- Differential Polymerase Chain Reaction Assay of Cyclin Dl Gene Amplification in Esophageal CarcinomaDiagnostic Molecular Pathology, 1994